NO20055227L - Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav - Google Patents

Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav

Info

Publication number
NO20055227L
NO20055227L NO20055227A NO20055227A NO20055227L NO 20055227 L NO20055227 L NO 20055227L NO 20055227 A NO20055227 A NO 20055227A NO 20055227 A NO20055227 A NO 20055227A NO 20055227 L NO20055227 L NO 20055227L
Authority
NO
Norway
Prior art keywords
chemoattractant
methods
stem cells
increased sensitivity
preparation
Prior art date
Application number
NO20055227A
Other languages
English (en)
Norwegian (no)
Inventor
Tsvee Lapidot
Orit Kollet
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL15530303A external-priority patent/IL155303A0/xx
Priority claimed from IL15930703A external-priority patent/IL159307A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO20055227L publication Critical patent/NO20055227L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/12—Hepatocyte growth factor [HGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20055227A 2003-04-08 2005-11-07 Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav NO20055227L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL15530303A IL155303A0 (en) 2003-04-08 2003-04-08 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
IL15930703A IL159307A0 (en) 2003-12-10 2003-12-10 Stem cells having increased sensitivity to a chemo-attractant and methods of generating and using same
PCT/IL2004/000315 WO2004090121A2 (fr) 2003-04-08 2004-04-07 Cellules souches presentant une sensibilite accrue a un agent chimio-attractif, methodes de production et d'utilisation associees

Publications (1)

Publication Number Publication Date
NO20055227L true NO20055227L (no) 2005-11-07

Family

ID=33161264

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055227A NO20055227L (no) 2003-04-08 2005-11-07 Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav

Country Status (8)

Country Link
US (1) US8029780B2 (fr)
EP (1) EP1613742A2 (fr)
JP (2) JP4865541B2 (fr)
AU (1) AU2004227205B2 (fr)
CA (1) CA2519975C (fr)
IL (2) IL171254A (fr)
NO (1) NO20055227L (fr)
WO (1) WO2004090121A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2647201C (fr) 2006-03-24 2016-03-08 Children's Medical Center Corporation Procede permettant de moduler la croissance de cellules souches hematopoietiques
JP5426389B2 (ja) 2006-10-20 2014-02-26 チルドレンズ メディカル センター コーポレーション 組織の再生を亢進するための方法
EP2094839B1 (fr) 2006-12-08 2020-02-05 University of Rochester Expansion de cellules souches hématopoïétiques
WO2009134532A2 (fr) * 2008-03-07 2009-11-05 The Trustees Of Columbia University In The City Of New York Homing dans des cellules souches mésenchymateuses
CA3203374A1 (fr) 2008-11-06 2010-05-14 Indiana University Research & Technology Corporation Materiaux et procedes ameliorant les protocoles de prise de greffe de cellules souches hematopoietiques
BR112014007782B1 (pt) 2011-09-30 2021-06-01 Bluebird Bio, Inc. Método para aumentar a eficiência de transdução lentiviral de células progenitoras ou células-tronco hematopoiéticas cd34+, bem como usos terapêuticos de composição compreendendo as ditas células e de pge2, 16,16-dimetil pge2, ou seu análogo
AU2012321088B8 (en) * 2011-12-02 2016-12-15 Fate Therapeutics, Inc. Enhanced stem cell composition
US10162168B2 (en) 2013-05-03 2018-12-25 Wilcox Industries Corp. Binocular bridge for thermal viewing device
US11326183B2 (en) 2016-02-12 2022-05-10 Bluebird Bio, Inc. VCN enhancer compositions and methods of using the same

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622853A (en) * 1990-05-01 1997-04-22 Becton Dickinson And Company T lymphocyte precursor
ES2143990T3 (es) * 1991-07-26 2000-06-01 Toray Industries Utilizacion de factores de crecimiento de hepatocitos para la fabricacion de un multiplicador de celulas cepa hematopoyeticas.
DE4422667A1 (de) * 1994-06-30 1996-01-04 Boehringer Ingelheim Int Verfahren zur Herstellung und Züchtung hämatopoetischer Vorläuferzellen
IT1271088B (it) * 1994-11-24 1997-05-26 Dompe Spa Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche
KR100725199B1 (ko) * 1995-08-29 2007-08-16 안제스에무지 가부시키가이샤 에이치지에프유전자를함유하는약제
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
WO1999015628A1 (fr) * 1997-09-25 1999-04-01 Glycotech Corporation Procedes et compositions utilises pour lier des cellules souches hematopoietiques
JP3962459B2 (ja) * 1997-10-28 2007-08-22 麒麟麦酒株式会社 造血幹細胞の分化・増殖調節方法
WO1999061584A1 (fr) * 1998-05-29 1999-12-02 Thomas Jefferson University Compositions et methodes utilisees pour modifier des populations de cellules souches hematopoietiques chez des mammiferes
IL125532A0 (en) * 1998-07-27 1999-03-12 Yeda Res & Dev Hematopoietic cell composition for use in transplantation
KR20020013480A (ko) * 1998-12-04 2002-02-20 추후기재 사람 뇌의 내피세포 및 성장배지 및 원시 ｃｄ34+ｃｄ38-골수 간세포의 증가방법
KR20020013496A (ko) * 1999-02-04 2002-02-20 추후제출 조혈 간세포 및(또는) 전구세포의 유지 및 증대 방법 및장치
EP1312668A4 (fr) * 2000-08-25 2004-07-07 Asahi Chemical Ind Milieu de culture de cellule souche et procede de culture utilisant ce milieu
GB0031390D0 (en) * 2000-12-21 2001-02-07 Imp College Innovations Ltd Methods
WO2002079457A1 (fr) * 2001-03-29 2002-10-10 Ixion Biotechnology, Inc. Procede de transdifferentiation de cellules souches non pancreatiques dans la voie de differentiation du pancreas
DK1414996T3 (da) * 2001-07-10 2011-03-21 Johnson & Johnson Res Pty Ltd Fremgangsmåder til genetisk modifikation af hæmatopoetiske progenitorceller og anvendelser af modificerede celler

Also Published As

Publication number Publication date
CA2519975C (fr) 2013-07-02
EP1613742A2 (fr) 2006-01-11
IL200207A (en) 2012-06-28
WO2004090121A3 (fr) 2004-12-29
US8029780B2 (en) 2011-10-04
JP2010263907A (ja) 2010-11-25
AU2004227205B2 (en) 2010-06-10
WO2004090121A2 (fr) 2004-10-21
JP2006522604A (ja) 2006-10-05
JP5362659B2 (ja) 2013-12-11
CA2519975A1 (fr) 2004-10-21
US20070172464A1 (en) 2007-07-26
AU2004227205A1 (en) 2004-10-21
JP4865541B2 (ja) 2012-02-01
IL171254A0 (en) 2011-08-01
IL200207A0 (en) 2011-08-01
IL171254A (en) 2013-06-27

Similar Documents

Publication Publication Date Title
NO20055227L (no) Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
NO2019004I1 (no) patisiran: dekket gjennom sekvensene i kravene 1, 8 og 9 (se særlig krav 8 (b) og (c) i patentet. Det vises også til følgebrevet til søknaden.
NO20080067L (no) Polypeptider som har antimikrobeaktivitet og polynukleotider som koder for disse
NO20083153L (no) Kjemiske forbindelser
NO20055211L (no) Anti-fungale forbindelser og fremgangsmater for anvendelse
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
DK1954811T3 (da) Inducerbare ekspressionssystemer
NO20074853L (no) Smamolekylinhibitorer av MDM2 og anvendelser derav
AR056256A1 (es) Plantas resistentes al estres
BRPI0414593A (pt) derivados de ácido sulfonamida substituìda-indol-2-carboxìlico como inibidores de pai-1
WO2006131928A3 (fr) Nouvelles sequences de nucleotides et d'acides amines, leurs dosages et methodes d'utilisation en vue du diagnostic
NO20083324L (no) Multisykliske aminosyrederivater og anvendelse derav
NO20076001L (no) Tigecyklin og metoder for deres fremstilling
NO20075998L (no) Tigecyklin og metoder til fremstilling av 9-aminominocyklin
NO20075997L (no) Methoder til furifysering av tigecyklin
BRPI0414599A (pt) pirrol-indóis substituìdos
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
CY1111151T1 (el) Αναστολεις φωσφολιπασης α2 του κυτταροδιαλυματος
NO20076072L (no) Tigecyklin og metoder for fremstilling av 9-nitrominocyklin
NO20071840L (no) Ikke-peptid bradykininantagonister og farmasoytiske sammensetninger derav.
NO20072966L (no) Polypeptider som har antimikrobeaktivitet og polynukleotider som koder for disse
NO20081470L (no) Polypeptider som har antimikrobeaktivitet og polynukleotider som koder for disse.
NO20084290L (no) Process to prepare sulfonyl chloride derivatives
NO20075227L (no) Treatment of eczemas